Epigral Sets Rs 5,000 Crore Revenue Target for FY31
Epigral is targeting Rs 5,000 crore in revenue by the financial year 2030-31, driven by chemical capacity expansion, as reported by Indiatimes on 28 September 2026. No further details on the specific scope, locations or phasing of the expansion were available from the published headline.
| Detail | Information |
|---|---|
| Promoter | Epigral |
| Revenue Target | Rs 5,000 crore |
| Target Year | FY31 |
| Basis | Chemical capacity expansion |
Epigral's Existing Projects Already Tracked
Projects India currently tracks two Epigral projects in Bharuch, Gujarat. The first is a Synthetic Organic Chemical Manufacturing Unit valued at Rs 2,127 crore. The second is a Chlorinated Polyvinyl Chloride (CPVC) Manufacturing Unit at Dahej, Bharuch, for which a project value has not been recorded. Both projects are located in Gujarat, which remains the dominant state for chemicals investment in India.
Gujarat Leads India's Chemicals Project Pipeline
The scale of Epigral's ambitions sits within a broader chemicals investment landscape concentrated heavily in Gujarat. Of the 2,698 chemicals projects tracked across India by Projects India, 1,672 are located in Gujarat — more than any other state. Maharashtra is a distant second with 336 tracked projects, followed by Andhra Pradesh with 119, Telangana with 68, Karnataka with 66 and Rajasthan with 64.
Thirty-three new chemicals projects were added to the tracked pipeline in the last 90 days alone, reflecting sustained investment momentum in the sub-sector. Recent examples from the tracked pipeline include a Rs 4,000 crore Specialty Chemicals project by UPL Limited at Paradip, Odisha, currently under construction, and a Rs 2,000 crore Silicon-Carbon Anode Material project by Himadri Advanced New Energy Materials Limited at Dhenkanal, Odisha, which has received approvals.
Stage Breakdown: Where Projects Stand Across the Pipeline
Among the 2,698 chemicals projects tracked by Projects India, the largest share — 940 — are at the Under Approvals stage, indicating a substantial volume of investment still moving through regulatory processes. A further 405 projects are at the Construction Started stage, representing near-term procurement and contracting opportunities. The full stage breakdown is as follows:
- Under Approvals: 940 projects
- Completed: 687 projects
- Construction Started: 405 projects
- Hold: 189 projects
- Approvals Received: 167 projects
- Planning: 161 projects
Projects at the Approvals Received and Planning stages — totalling 328 combined — represent an early-stage pipeline that suppliers and contractors can begin to monitor ahead of tendering. For a broader view of active industrial projects across India, including chemicals, the Projects India sector overview provides a consolidated picture.
What this means for suppliers and contractors
Epigral's stated revenue ambition, underpinned by capacity expansion, signals potential procurement activity in the chemicals sub-sector, particularly in Gujarat where both of its tracked projects are located. Suppliers of process equipment, engineering services and specialty raw materials operating in the Bharuch-Dahej corridor should monitor project-stage developments for both the Synthetic Organic Chemical and CPVC units already in the pipeline.
More broadly, with 405 chemicals projects nationally at the Construction Started stage and a further 167 that have received approvals, the near-term order book for contractors and equipment suppliers across Gujarat, Maharashtra and Andhra Pradesh remains substantive. The 940 projects still under approvals represent a forward pipeline that warrants early engagement. Suppliers can track live project movements and open tenders through Projects India's platform, where all 2,698 tracked chemicals projects are maintained with stage and location data.
For context on other recent fundraising and investment activity in the sector, see also coverage of related chemicals investments tracked on the platform, including IOL Chemicals' Rs 350 crore ibuprofen expansion.
Frequently asked questions
What is Epigral's revenue target and by when?
Epigral is targeting Rs 5,000 crore in revenue by FY31 (financial year 2030-31), driven by chemical capacity expansion, as reported by Indiatimes on 28 September 2026. No further breakdown of the expansion scope was available from the published report.
What Epigral projects are currently being tracked in India?
Projects India tracks two Epigral projects, both in Bharuch, Gujarat: a Synthetic Organic Chemical Manufacturing Unit valued at Rs 2,127 crore, and a CPVC Manufacturing Unit at Dahej, Bharuch, for which no project value has been recorded.
How many chemicals projects are active in India right now?
Projects India tracks 2,698 chemicals projects across India, with 405 at the Construction Started stage and 940 still under approvals. Gujarat dominates with 1,672 tracked projects, followed by Maharashtra with 336 and Andhra Pradesh with 119.
